You will be pleased to hear that the European Commission has clinical trials in its sites. Among other things, it wants to ensure that people involved in multi-centre trials are not subject to disproportionate risk, and that their treatment is properly assessed by an ethics committee before it gets the ...

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here